risk-assessment
Topic | Replies | Views | Activity | |
---|---|---|---|---|
πͺπΊ EDQM - top 10 deficiencies observed in new CEP applications | 0 | 279 | March 14, 2024 | |
πΊπΈ FDA CDER Generic Drug Forum (GDF) 2024 | 3 | 332 | March 14, 2024 | |
Identifying the Risk of Formation of Nitrosamines and Other Potentially Mutagenic Impurities during API Manufacture Using In Silico Risk Assessment -Pub | 0 | 1002 | June 6, 2023 | |
Nitrosamine Risk Assessments in Oligonucleotides | 2 | 423 | August 10, 2023 |